Research facility · founded 1898
Roswell Park Comprehensive Cancer Center
Buffalo, United States · roswellpark.org
- Citations, last 5 years
- 77.5k
- Works, last 5 years
- 6 260
- h-index
- 729
- Scientists listed
- 671
- Grants since 2016
- 750
Grants received
2022–2027 · research · R01
Delineating the dystopian nature of the cell cycle in cancer
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2026 · research · R01
STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity
Joyce Ellen Ohm · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication
Marilyn L Kwan · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine
Maciej Lukasz Goniewicz · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2023 · fellowship · F99
Impact of Numeracy on Risk Perceptions of Tobacco-Related Diseases
Destiny Diaz · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication
Marilyn L Kwan · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Data and Resource Coordination Center for Cancer Prevention-Interception Targeted Agent Discovery Program
Alan David Hutson · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U24
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
Alan David Hutson · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Implementation of evidence-based strategies to optimize HPV vaccination in rural primary care settings
Elisa Marie Rodriguez · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2025 · research · R03
CRISPR-mediated engineering and pilot study of mouse mutants of the bitter taste receptor genes
Eugene Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
Brahm H. Segal · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Investigating how stress induced changes in maternal serotonin affect offspring development and stress resilience
Veena Prahlad · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2026 · research · R01
STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity
Joyce Ellen Ohm · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
Eugene Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine
Maciej Lukasz Goniewicz · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2026 · research · R00
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GVT) Responses
Hemn Mohammadpour · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2025 · research · R00
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GVT) Responses
Hemn Mohammadpour · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2026 · research · R01
STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity
Joyce Ellen Ohm · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine
Maciej Lukasz Goniewicz · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Implementation of evidence-based strategies to optimize HPV vaccination in rural primary care settings
Elisa Marie Rodriguez · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
Brahm H. Segal · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Investigating how stress induced changes in maternal serotonin affect offspring development and stress resilience
Veena Prahlad · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2026 · research · R01
STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity
Joyce Ellen Ohm · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Delineating the dystopian nature of the cell cycle in cancer
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
Eugene Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
Eugene Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer Progression
Jia Fang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2025 · fellowship · F30
The impact of chronic stress on radiation induced cell death and the anti-tumor immune response
Cameron Riker Macdonald · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2027 · cooperative agreement · UH3
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
Charles Stewart Kamen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
Subhamoy Dasgupta · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence
Elizabeth Bouchard · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Role of type 2 immune response in pancreatic cancer tumorigenesis
Prasenjit Dey · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2027 · cooperative agreement · UG3
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
Charles Stewart Kamen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2023 · award
Cytochrome c-deficiency in African American men with prostate cancer
Dhyan Chandra · Roswell Park Comprehensive Cancer Center · funded by American Cancer Society
2021–2026 · research · R01
Metformin for chemoprevention of lung cancer in obese subjects at high risk
Joseph Barbi · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
Renier Joseph Brentjens · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
Renier Joseph Brentjens · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Understanding mechanisms and consequences of T cell co-receptor regulated RNA maturation
Scott Henry Olejniczak · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
Gyorgy Paragh · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
